María Isabel Morosini-rekin lankidetzan egindako argitalpenak (5)

2003

  1. Erratum: Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation (Antimicrobial Agents and Chemotherapy (2003) 47:4 (1464-1467))

    Antimicrobial Agents and Chemotherapy

  2. Frequency of mutation to rifampin resistance in Streptococcus pneumoniae clinical strains: hexA and hexB polymorphisms do not account for hypermutation

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 4, pp. 1464-1467

  3. Haemophilus influenzae blaROB-1 mutations in hypermutagenic ΔampC Escherichia coli conferring resistance to cefotaxime and β-lactamase inhibitors and increased susceptibility to cefaclor

    Antimicrobial Agents and Chemotherapy, Vol. 47, Núm. 8, pp. 2551-2557

2002

  1. Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 2, pp. 528-530

1998

  1. An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection

    FEMS Microbiology Letters, Vol. 165, Núm. 1, pp. 85-90